Skip to main content
Clinical Trials/JPRN-UMIN000015966
JPRN-UMIN000015966
Recruiting
未知

Clinical benefit of measurement of advanced glycogen endproduct level in type 2 diabetes - Clinical benefit of measurement of advanced glycogen endproduct level in type 2 diabetes

Human Ethics Review Committee of Kumamoto University0 sites200 target enrollmentDecember 16, 2014
ConditionsType 2 Diabetes

Overview

Phase
未知
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Human Ethics Review Committee of Kumamoto University
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 16, 2014
End Date
March 31, 2024
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Human Ethics Review Committee of Kumamoto University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with infectious disease 2\. Patients with acute/chronic inflammatory disease 3\. Patients with cancer 4\. Patients with acute cerebrovascular disease 5\. Patients with severe hepatic disease 6\. Patients with severe respiratory 7\. Patients with mental disorder 8\. Patients decided from attended doctors not to be recruited in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials